Cannabigerol potentiates rivoceranib in hepatocellular carcinoma through a receptor-independent ER stress–calcium program that collapses the E2F1

An article created on 2026-08-20 08:36:45

#	Наименование новости	Информативность	Дата публикации
1	The Role of LINC00261 in Pancreatic Cancer Progression: Implications for EMT and FOXA2 Regulation	25	20-08-2026
2	miR-325-3p Facilitates Tumorigenesis and Acquired Pemigatinib Resistance in Intrahepatic Cholangiocarcinoma via Targeting ADH1B through Epithelial–Mesenchymal Transition and PI3K/AKT Signaling	20.74	20-08-2026
3	Novel senolytic and senescence-suppressing compounds overcome senescence-driven chemoresistance in NSCLC	28.75	20-08-2026
4	Loss of SARA in Hepatic Stellate Cells Exacerbates Experimental Liver Fibrosis	15.88	20-08-2026
5	Time to Sustained CEA Elevation From Start of First-Line Therapy Predicts Initial Treatment Efficacy and Clinical Outcomes in Lung Adenocarcinoma	17.69	20-08-2026
6	TOX3 drives hepatocellular carcinoma progression by suppressing the p53-p21-Rb pathway	22.5	11-08-2026
7	Identification of Novel Candidate Inhibitors Targeting hBCATm for Acute Liver Failure by In Silico Methods	14.76	10-08-2026
8	Exercise ameliorates sarcopenia and metabolic dysfunction–associated steatohepatitis through activation of skeletal muscle PGC-1α/SIRT1 signaling in mice	14.55	20-08-2026
9	Fucoxanthin induces apoptosis in acute lymphoblastic leukaemia cell line by damaging the endoplasmic reticulum	15	10-08-2026

Классификация: Наука. Схожих патентов: 0. Схожих новостей: 9. Тональность: 0. Информативность: 18.7. Источник: www.researchsquare.com.

Найдите то, что Вас интересует